Shanghai Raas Blood Products Co.Ltd(002252) : short form equity change report

Shanghai Raas Blood Products Co.Ltd(002252)

Short form equity change report

Listed company: Shanghai Raas Blood Products Co.Ltd(002252) place of listing: Shenzhen Stock Exchange Stock abbreviation: Shanghai Raas Blood Products Co.Ltd(002252) Stock Code: Shanghai Raas Blood Products Co.Ltd(002252) name of information disclosure obligor: Kerui Tiancheng Investment Holding Co., Ltd

Main business premises: floor 1, building 28, No. 6055, Jinhai highway, Fengxian District, Shanghai

Name of information disclosure obligor (acting in concert): Ningbo Kerui Jinding investment partnership (limited partnership)

Main business premises: Room 401, building 1, No. 88, Meishan Qixing Road, Beilun District, Ningbo City, Zhejiang Province f0560 information disclosure obligor (acting in concert) Name: Kerui Group Co., Ltd. address and mailing address: room 603, R & D building 3, Xianfeng software, No. 948, torch Avenue, Nanchang high tech Industrial Development Zone, Nanchang City, Jiangxi Province

Nature of share change: share reduction (passive reduction)

Date of signature: May 23, 2022

Statement of information disclosure obligor

1、 The information disclosure obligor prepares this report in accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the measures for the administration of the acquisition of listed companies, the standards for the content and format of information disclosure by companies that publicly issue securities No. 15 – Report on changes in equity and other relevant laws and regulations.

2、 The information disclosure obligor has obtained necessary authorization and approval for signing this report, and its performance does not violate or conflict with the articles of association, agreement or any other terms in any form signed by the information disclosure obligor. 3、 In accordance with the securities law of the people’s Republic of China and the measures for the administration of the acquisition of listed companies, this report has fully disclosed the changes in shares in which the information disclosure obligor has an interest in Shanghai Raas Blood Products Co.Ltd(002252) shares. As of the trading day before the signing date of this report, except for the information disclosed in this report, the information disclosure obligor has not increased or reduced its shares in Shanghai Raas Blood Products Co.Ltd(002252) by any other means.

4、 This equity change is based on the information stated in this report. Except for the information disclosure obligor, no other person has been entrusted or authorized to provide information not listed in this report and make any explanation or explanation to this report.

5、 The information disclosure obligor promises that there are no false records, misleading statements or major omissions in this report, and will bear individual and joint legal liabilities for its authenticity, accuracy and completeness.

catalogue

The disclosure obligor declares that 2 catalog Section 1 interpretation Section 2 Introduction to information disclosure obligors and persons acting in concert five

1、 Basic information of information disclosure obligor five

2、 Basic information of persons acting in concert of information disclosure obligors six

3、 Relationship between information disclosure obligors Section III purpose of equity change ten

1、 The purpose of this equity change 2. Information disclosure obligors increase or continue to decrease their equity shares in Listed Companies in the next 12 months

Situation Section 10 equity changes eleven

1、 Shareholding of information disclosure obligor eleven

2、 The way of this equity change eleven

3、 Restrictions on the rights and interests of information disclosure obligors twelve

4、 The impact of this equity change on the listed company twelve

Section V Trading of listed shares by the information disclosure obligor within the first six months thirteen

Section VI other major matters Section VII declaration of information disclosure obligor Section VIII documents for future reference 18 schedule: nineteen

Section I interpretation

In this report, unless otherwise specified, the following abbreviations have the following meanings:

This report refers to Shanghai Raas Blood Products Co.Ltd(002252) simplified equity change report

Shanghai Raas Blood Products Co.Ltd(002252) , listed company, the company refers to Shanghai Raas Blood Products Co.Ltd(002252) company, the company’s information disclosure obligor, and Kerui Tiancheng refers to Kerui Tiancheng Investment Holding Co., Ltd

Kerui group refers to Kerui Group Co., Ltd

Ningbo Kerui Jinding refers to Ningbo Kerui Jinding investment partnership (limited partnership)

Raffles China means RAAS China Limited

Killiffer means Grifols, S.A

This equity change refers to the reduction of shareholding ratio by more than 5% due to the passive reduction factors contained in this report

This transaction refers to Shanghai Raas Blood Products Co.Ltd(002252) purchasing 40 outstanding series a common shares of GDS (accounting for 40% of 100 outstanding series a common shares of GDS) and 50 outstanding Series B common shares of GDS by issuing shares (accounting for 50% of the 100 Series B common shares issued by GDS), with a total of 45% equity of GDS.

Company Law refers to the company law of the people’s Republic of China

Securities Law refers to the securities law of the people’s Republic of China

The acquisition Measures refer to the administrative measures for the acquisition of listed companies

Standard No. 15 refers to Standard No. 15 on the contents and forms of information disclosure by companies offering securities to the public – Report on changes in equity

CSRC / CSRC refers to the China Securities Regulatory Commission

Shenzhen stock exchange refers to Shenzhen Stock Exchange

Yuan and 10000 yuan refer to RMB yuan and 10000 yuan

Note: there may be a tail difference between the sum of individual data and the total amount of relevant data in this report, which is caused by rounding in data calculation.

Section II introduction to information disclosure obligors and persons acting in concert

1、 Basic information of information disclosure obligor

1. Basic information

Company name: Kerui Tiancheng Investment Holding Co., Ltd

Unified social credit code 91360106742602991x

Enterprise type: other limited liability companies

Date of establishment: October 31, 2002

Registered address: floor 1, building 28, No. 6055, Jinhai Road, Fengxian District, Shanghai

Legal representative: Wu Xu

The registered capital is 520 million yuan

Business term: October 31, 2002 to October 30, 2042

Business scope: investment and investment management, investment consulting, financial consulting, real estate information consulting, engaged in technology development, technical consulting, technical services, technology transfer and conference services in the fields of biotechnology and pharmaceutical science and technology. [for projects subject to approval according to law, business activities can be carried out only after approval by relevant departments]

2. Ownership structure

Sequence shareholder name subscribed capital contribution (10000 yuan) shareholding proportion No

1 Ningbo Zhengxiang Runsheng investment partnership (limited partnership) 1040020.00%

2 Shenzhen Yixuan Capital Management Co., Ltd. 1040020.00%

3 Beijing Fuli Asset Management Co., Ltd. 767014.75%

4 Wuhan jiangrui consulting service partnership (limited partnership) 572011.00%

5 Guangcai Industrial Co., Ltd. 520010.00%

6 Beijing Hongan Tairen Business Management Co., Ltd. 4680 9.00%

7 Baibuting Group Co., Ltd. 3250 6.25%

8 Shanghai rundai Industrial Development Co., Ltd. 3120 6.00%

9 Ningbo shanyong Investment Co., Ltd. 1560 3.00%

Total 52 Tcl Technology Group Corporation(000100) .00%

3. Basic information of directors and main principals

Name Gender employment in Kerui Tiancheng nationality long-term residence whether to obtain the right of residence in other countries or regions

Zheng Yuewen, chairman of China no

Wu Xunan, vice chairman and executive director, Hong Kong, China no

general manager

Mao Yonghong male Director China no

Lin Mingzhang male Director China no

Yuan Kequn, male director, China no

Zeng Lingshan male Director China no

Guo Hengnan Director China no

4. Shares with interests in other domestic and overseas listed companies reach or exceed 5% of the issued shares of the company

As of the signing date of this report, Kerui Tiancheng has no shares with interests in other domestic and overseas listed companies that reach or exceed 5% of the issued shares of the company. 2、 Basic information of persons acting in concert of information disclosure obligors (I) Kerui Group Co., Ltd. 1. Basic information

Company name: Kerui Group Co., Ltd

Code for unified social information 913601061583459064

Enterprise type: limited liability company (invested or controlled by natural person)

Date of establishment: September 5, 1991

Registered address: room 603, R & D building, No. 3, Xianfeng software, No. 948, torch Avenue, Nanchang high tech Industrial Development Zone, Nanchang City, Jiangxi Province

Legal representative: Zheng Yuewen

The registered capital is 130 million yuan

Business term: January 5, 2000 to long term

Business scope: development, production and technology transfer of high-tech products; Sales of ordinary machinery, chemical raw materials and products (except precursor and dangerous chemicals), biological products, electronic products, communication equipment, chemical engineering and equipment for energy procedures; estate management; House leasing; Information services and investment consulting services; Equipment leasing; Mining investment; China trade. (for projects subject to approval according to law, business activities can be carried out only after approval by relevant departments)

2. Ownership structure

No. shareholder name subscribed capital contribution (10000 yuan) shareholding ratio

1 Zheng Yuewen 702054%

2 Lin Mingzhang 338026%

3 Zeng Lingshan 260020%

-Total